Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
The British Journal of Surgery|August 10, 2018
Nationwide population-based study of trends and regional variation in breast-conserving treatment for breast cancerM C van Maaren, L J A Strobbe, L B Koppert, et al.Breast Cancer Research and Treatment|October 13, 2016
Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patientsM C van Maaren, L de Munck, J J Jobsen, et al.BMC Cancer|November 14, 2023
Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series designA Klaassen-Dekker, C H C Drossaert, M C Van Maaren, et al.Breast Cancer Research and Treatment|October 4, 2023
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performedL M van Roozendaal, M L G Vane, E Colier, et al.Breast (Edinburgh, Scotland)|June 17, 2026
Factors associated with local breast cancer recurrence after mastectomy in the Netherlands: a retrospective nationwide cohort studyT D A Stindt, M C van Maaren, B V Offersen, et al.European Journal of Cancer (Oxford, England : 1990)|July 31, 2018
Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012M C van Maaren, M Lagendijk, M M A Tilanus-Linthorst, et al.Breast Cancer Research and Treatment|March 10, 2021
Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancerM Moossdorff, Marissa L G Vane, T J A van Nijnatten, et al.European Journal of Cancer (Oxford, England : 1990)|November 4, 2017
Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer populationM C van Maaren, C D van Steenbeek, P D P Pharoah, et al.Breast Cancer Research and Treatment|March 3, 2022
Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USAM A A Ragusi, B H M van der Velden, M C van Maaren, et al.Breast Cancer Research : BCR|October 19, 2019
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancerD J P van Uden, M C van Maaren, L J A Strobbe, et al.Pageof 2